MEDNAX to Host Two Premier Neonatology Meetings Feb. 17-22
14 Februar 2020 - 12:45PM
Business Wire
MEDNAX, Inc. (NYSE: MD), the nation’s leading provider of
maternal-fetal, newborn and pediatric subspecialty care, will host
two premier meetings in neonatal medicine this month at the
Manchester Grand Hyatt in San Diego. Specialty Review in
Neonatology and NEO: The Conference for Neonatology will take place
concurrently, each addressing many of the most critical and
controversial issues that influence the clinical practice of
newborn medicine. The meetings will host more than 700 combined
attendees.
Specialty Review in Neonatology | Feb. 17-22
Celebrating its 10th anniversary, Specialty Review is the
country’s leading review of its type, offering an intensive and
comprehensive review of neonatal medicine. The course is invaluable
to those preparing for subspecialty certifying examinations, as
well as new or current fellows in training seeking a fundamental
pathophysiology and problem-based review of neonatal-perinatal
medicine.
Directed by David Weisoly, D.O., MEDNAX-affiliated
neonatologist, the six-day course will feature an elite lineup of
world-renowned speakers known for their excellence in teaching and
field expertise. Attendees will also have the opportunity to
participate in the popular “Battle of the Boards” event. Now in its
fifth year, the Jeopardy-style rapid-fire team competition is
designed to enhance the learning experience in a fun, interactive
setting.
For more information, visit www.specialtyreview.com.
NEO: The Conference for Neonatology | Feb. 19-21
NEO has established a reputation as the top neonatology meeting
in the U.S. Directed by Reese Clark, M.D., Vice President of
Clinical Research for MEDNAX, and Timothy Biela, M.D.,
MEDNAX-affiliated neonatologist, NEO continues its longstanding
tradition of providing the latest information on key areas of
neonatal management. The goal of the meeting continues to be the
improvement of neonatal outcomes through expert discussions of
optimal approaches in the neonatal intensive care unit (NICU).
An esteemed panel of speakers comprised of well-recognized
faculty from top institutions across the country as well as several
MEDNAX-affiliated physicians will present over the course of three
days. New to this year’s agenda is “Ask the Expert!,” a roundtable
discussion focusing on respiratory treatments in the NICU and early
onset sepsis.
For more information, visit www.neoconference.com.
Specialty Review and NEO are accredited by the MEDNAX Center for
Research, Education, Quality and Safety, providing continuing
medical and nursing education credit for participating
clinicians.
ABOUT MEDNAX
MEDNAX, Inc. is a national health solutions partner comprised of
the nation's leading providers of physician services. Physicians
and advanced practitioners practicing as part of MEDNAX are
reshaping the delivery of care within their specialties and
subspecialties, using evidence-based tools, continuous quality
initiatives, consulting services, clinical research and
telemedicine to enhance patient outcomes and provide high-quality,
cost-effective care. The Company was founded in 1979, and today,
through its affiliated professional corporations, MEDNAX provides
services through a network of more than 4,325 physicians in all 50
states and Puerto Rico. Additional information is available at
www.mednax.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200214005076/en/
Jennifer Gutierrez 954-384-0175 ext. 5684
jennifer_gutierrez@mednax.com
Pediatrix Medical (NYSE:MD)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Pediatrix Medical (NYSE:MD)
Historical Stock Chart
Von Apr 2023 bis Apr 2024